TNF Pharmaceuticals, Inc. Common Stock (QCLS)
US — Technology Sector
Automate Your Wheel Strategy on QCLS
With Tiblio's Option Bot, you can configure your own wheel strategy including QCLS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives
QCLS
Published: October 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Published: October 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Dr. Frankel brings extensive knowledge and deep expertise that bridges advanced physics and quantum technologies New York, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C” or the “Company”), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Steven Frankel, Ph.D. as Senior Quantum Advisor.
Read More
About TNF Pharmaceuticals, Inc. Common Stock (QCLS)
- IPO Date 2025-09-25
- Website https://ir.tnfpharma.com/
- Industry Software - Services
- CEO None
- Employees None
Q/C Technologies, Inc. is focused on quantum-class photonic computing and blockchain infrastructure. The company has exclusive global rights to LightSolver's light-speed laser processing unit (LPU), a revolutionary light and laser-based computing system aimed at cryptocurrency vertical applications, reducing energy consumption by up to 90% while outperforming traditional GPUs and quantum computers.